Table 2.
Progression-free survival (PFS) | Overall survival (OS) | |||
---|---|---|---|---|
Hazard ratio 95% CI | P Value | Hazard ratio 95% CI | P Value | |
Decrease of Tumor Growth Rate* | 0.91 0.85 – 0.96 |
0.004 | 0.95 0.88 – 1.04 |
0.27 |
RMH prognostic score low score (0–1) vs. high score (2–3) | 1.42 0.96 – 2.08 |
0.08 | 2.53 1.47 – 4.34 |
0.0008 |
All the analyses reported are performed with the landmark method (landmark point was set to 56 days, n=157 patients analyzed).
To be clinically meaningfull, hazard ratios are computed for 10% variation in Tumor Growth Rate. Here, every 10% decrease in TGR between the REFRENCE and the EXPERIMENTAL periods results in a 9% decrease in the progression hazard.